NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
82 hedge funds and large institutions have $79.4M invested in Navidea Biopharmaceuticals Inc. in 2015 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 19 increasing their positions, 23 reducing their positions, and 13 closing their positions.
Holders
82
Holders Change
-5
Holders Change %
-5.75%
% of All Funds
2.19%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
8
Increased
19
Reduced
23
Closed
13
Calls
$286K
Puts
$9.75M
Net Calls
-$9.46M
Net Calls Change
+$2.68M
Top Buyers
1 |
1
Goldman Sachs
New York
|
$5.12M |
2 |
2
UBS Group
Zurich,
Switzerland
|
$2.51M |
3 |
TC
3
TFS Capital
West Chester,
Pennsylvania
|
$916K |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$7.18M |
5 |
5
State Street
Boston,
Massachusetts
|
$3.26M |